Cargando…

Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259137/
https://www.ncbi.nlm.nih.gov/pubmed/35813103
http://dx.doi.org/10.1097/HS9.0000000000000756
_version_ 1784741707234934784
collection PubMed
description
format Online
Article
Text
id pubmed-9259137
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92591372022-07-07 Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies Hemasphere Correction Notice Lippincott Williams & Wilkins 2022-07-05 /pmc/articles/PMC9259137/ /pubmed/35813103 http://dx.doi.org/10.1097/HS9.0000000000000756 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. Creative Commons Attribution License 4.0 (CCBY)This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (CreativeCommonsAttributionLicense4.0(CCBY)) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction Notice
Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_full Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_fullStr Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_full_unstemmed Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_short Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
title_sort correction notice: antifungal prophylaxis in acute myeloid leukemia: new drugs, new challenges? summary of the eha guideline on antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel-targeted therapies
topic Correction Notice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259137/
https://www.ncbi.nlm.nih.gov/pubmed/35813103
http://dx.doi.org/10.1097/HS9.0000000000000756